Type 1 diabetes, characterized by the immune system's attack on insulin-producing cells, demands action advocacy to amplify awareness, secure vital resources, and drive research for improved therapies and a potential cure. Join us in this session with Dr Sanjay Kalra and Dr Anil Kumar Vedwal on September 21 at 7:00 p.m. to learn more about measures to ensure equitable access to insulin, education, and healthcare for those affected.